These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9099410)
1. Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder--a study with magnetic resonance spectroscopy. Riedl U; Barocka A; Kolem H; Demling J; Kaschka WP; Schelp R; Stemmler M; Ebert D Biol Psychiatry; 1997 Apr; 41(8):844-50. PubMed ID: 9099410 [TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up. Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479 [TBL] [Abstract][Full Text] [Related]
3. Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania. Kato T; Inubushi T; Takahashi S J Clin Psychopharmacol; 1994 Oct; 14(5):330-5. PubMed ID: 7806688 [TBL] [Abstract][Full Text] [Related]
4. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation. Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442 [TBL] [Abstract][Full Text] [Related]
5. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468 [TBL] [Abstract][Full Text] [Related]
7. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C; J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872 [TBL] [Abstract][Full Text] [Related]
8. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration. Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132 [TBL] [Abstract][Full Text] [Related]
9. [Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment]. Daléry J; Dagens-Lafant V; De Bodinat C Encephale; 1997; 23(1):56-64. PubMed ID: 9172969 [TBL] [Abstract][Full Text] [Related]
10. Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels. Mauri MC; Laini V; Scalvini ME; Volonteri LS; Ferrari MS; Panza G Eur Rev Med Pharmacol Sci; 1999; 3(2):63-9. PubMed ID: 10827806 [TBL] [Abstract][Full Text] [Related]
11. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis. Goldberg JF; Harrow M J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035 [TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549 [TBL] [Abstract][Full Text] [Related]
13. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
14. Schizoaffective disorder: a form of schizophrenia or affective disorder? Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641 [TBL] [Abstract][Full Text] [Related]
15. Relationship between prophylactic effect of lithium therapy and family history of affective disorders. Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078 [TBL] [Abstract][Full Text] [Related]
17. No correlation between lithium serum levels and psychopathological features during the euthymic interval of patients with recurrent affective disorder. Lewitzka U; Scheffczyk R; Ritter D; Doucette S; Bauer M; Bschor T Pharmacopsychiatry; 2012 Jan; 45(1):1-6. PubMed ID: 21989601 [TBL] [Abstract][Full Text] [Related]
18. Short TE (7) Li-MRS confirms Bi-exponential lithium T2 relaxation in humans and clearly delineates two patient subtypes. Port JD; Rampton KE; Shu Y; Manduca A; Frye MA J Magn Reson Imaging; 2013 Jun; 37(6):1451-9. PubMed ID: 23148051 [TBL] [Abstract][Full Text] [Related]
19. [Predictors of prophylactic response to lithium]. Rohayem J; Baylé JF; Richa S Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242 [TBL] [Abstract][Full Text] [Related]
20. Slow-release lithium in treatment of schizoaffective syndromes. Romeo R; Bastianello S; Janiri L; Mauro P; Pirrongelli C Int J Clin Pharmacol Res; 1985; 5(3):205-11. PubMed ID: 4018956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]